FDA CONSUMER HEALTH INFORMATION - FDA's MedWatch Safety Alerts: July 2011

Aug 22, 2011, 11:44 ET from U.S. Food and Drug Administration

SILVER SPRING, Md., Aug. 22, 2011 /PRNewswire-USNewswire/ --Recently issued safety alerts about products regulated by the Food and Drug Administration (FDA) include

  • new data on effectiveness and an increased risk of heart problems with a popular drug to help quit smoking
  • drug interactions involving certain psychiatric medications that may cause nervous system problems
  • "dietary supplements" for weight loss that contain a controlled substance
  • surgery using mesh to repair pelvic organ prolapse and stress urinary incontinence that may expose women to a greater risk of complications than would other forms of surgery

(Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO)

These and other alerts were prompted by reports FDA received from health care professionals and the public through the agency's MedWatch Adverse Event Reporting Program.

Learn more about these safety alerts and what to do if you've used one of the products described here.

Sign up for e-mail notices of new FDA Consumer Updates at

View the FDA Consumer Update RSS feed at

FDA Consumer Updates may be posted and published elsewhere without permission. Please credit "FDA Consumer Health Information (www.fda.gov/consumer)" as the source. FDA values feedback on its consumer health information. Send questions, comments, or story ideas to: consumerinfo@fda.hhs.gov.

Media Contact: Jason Brodsky, 301-796-8234, Jason.Brodsky@fda.hhs.gov

SOURCE U.S. Food and Drug Administration